Maria Simonenko 1 *,Dominique Hansen 2,3,Josef Niebauer 4,Maurizio Volterrani 5,Stamatis Adamopoulos 6,Cristiano Amarelli 7,Marco Ambrosetti 8,Stepfan D. Anker 9 Elena Cavarretta 1 4,1 5,Ovidiu Chioncel 1 6,1 7,Andrew JS Coats 1 8,Alain Cohen-Solal 1 9,Flavio d'Ascenzi 20,Carmen de Pablo Zarzosa,Carmen de Pablo Zarzosa,2 2 2,2 2,Gesta B,GESTA B,GESTA B,GESTA B,ANDRE ANDRE ANDRE 24,HELLELS 27,HILLE JANTMA,jANK 226,TINNINE JANE,TINNY JARE。 A 30,Emer Joyce 3 1,32,Nicolle Krankel 33,Mitja Lainscak 34,Lars H. 8,Elena Osto 39,40,Massimo Piepoli 4 1,42,Luciano Potena 43,Amina Rakisheva,Amina Rakisheva 44,45汤普森49,汤普森和C.汤普森
玛丽亚11,斯科特·鲍尔(Scott Wowel)12,弗朗西斯(Frances)13,吉西佩普5(Giusepep 5外套18,Alain 28,29,Emer Joyce 31:32,Nicolle Scratchet 33,Mithscak 34,Lars H. 41,42,Luciano Potena 43,Sphereovic 48,David R.外套18,Alain 28,29,Emer Joyce 31:32,Nicolle Scratchet 33,Mithscak 34,Lars H. 41,42,Luciano Potena 43,Sphereovic 48,David R.
玛丽亚11,斯科特·鲍尔(Scott Wowel)12,弗朗西斯(Frances)13,吉西佩普5(Giusepep 5外套18,Alain 28,29,Emer Joyce 31:32,Nicolle Scratchet 33,Mithscak 34,Lars H. 41,42,Luciano Potena 43,Sphereovic 48,David R.外套18,Alain 28,29,Emer Joyce 31:32,Nicolle Scratchet 33,Mithscak 34,Lars H. 41,42,Luciano Potena 43,Sphereovic 48,David R.
Maria 11,Scott Bowel 12,Frances 13,Giusepep 5,Elena Cavaret 14.15,Cyology 16:17,Andrew J.S. 外套18,Alain 28,29,Emer Joyce 31:32,Nicolle Scratchet 33,MithScak 34,Lars H.Maria 11,Scott Bowel 12,Frances 13,Giusepep 5,Elena Cavaret 14.15,Cyology 16:17,Andrew J.S.外套18,Alain 28,29,Emer Joyce 31:32,Nicolle Scratchet 33,MithScak 34,Lars H.
1多伦多媒介研究所,M5S 1M1,加拿大2,多伦多大学化学系,多伦多大学,圣乔治校园,多伦多,多伦多,加拿大,加拿大,加拿大34132 Kassel,34132 KASSEL,34132 KASSEL,34132 KASSEL,34132 KASSEL,40 Heinrich-Plett-Straße40,34132德国Kassel,5维也纳大学,物理学院,Kolingasse 14-16,AT-1090 AT-1090 WIEN,奥地利6化学系 - Ångström实验室,Uppsala大学,Uppsala University,uppsala University,box 538多伦多的乔治街,位于加拿大M5S 3H6上,8能源转换和存储部,DTU,Anker Engelunds VEJ,DK-2800公斤。Lyngby, Denmark 9 Department of Materials Science and Engineering, University of Toronto, St. George campus, Toronto, ON, Canada 10 Department of Physics, University of Toronto, St. George campus, Toronto, ON, Canada 11 Machine Learning Group, Technische Universität Berlin and Berlin Institute for the Foundations of Learning and Data, Berlin, Germany ∗ Author to whom any correspondence should be addressed.
目标指导的行为需要有意识和潜意识引起的反应冲突。神经元增益控制增强了加工效率,对于解决方案至关重要,尽管它面临固有的物理限制,但可以通过药理或脑刺激干预措施来增加。这项研究检查了阳极经颅直流电流刺激(ATDCS)和哌醋甲酯(MPH)对冲突处理的影响。健康的成年人(n = 105)执行了一项艰巨的任务,脑电图(EEG)用于评估α和theta带活性(ABA,TBA)。结果表明,将ATDC与MPH相结合的增强认知控制和减少反应冲突比仅与ATDC相结合,尤其是当两种冲突类型的类型共同发生时。ATDC和ATDCS + MPH均表现出(前)补充运动区域中相似的任务诱导的ABA和TBA调制,表明增益控制增强。重叠的额叶中部区域的神经解剖学效应表明,ATDC和MPH具有共同的神经元控制机制,尤其是在高频道/需求的情况下。
健康II活动参与,死亡率和入学:丹麦队列研究Linda Juel Ahrenfeldt 1,Tobias Anker Stripp 1,2,3,JensSøndergaard1和SörenMöller4.5。1 1研究部,SDU卫生服务部研究部2,2人类蓬勃发展计划,哈佛大学定量社会科学研究所,剑桥,哥本哈根科学与信仰中心3,哥本哈根,4个开放患者数据探索网络,OUH,5 ......................................................................................... 161 Triangulation of Contradictory Evidence From Three Randomized Trials of An Early 2-Dose Measles Schedule in Guinea-Bissau From 2003-2019 Sebastian Nielsen, Bandim Health Project, Department of Clinical Research, SDU, and Sdu, and Sören Möller, Open Patient Data Explorative Network (Open), Department of Clinical Research, University of Southern Denmark ........................................................... 173 Estimating Healthcare Transitions: Integrating Logistic Regression and Markov Models to Predict Mortality from Continuity and Discoontinuity of Care Troels Kristensen,Dache,丹麦南部公共卫生系.......................................................................................................................................................................1研究部,SDU卫生服务部研究部2,2人类蓬勃发展计划,哈佛大学定量社会科学研究所,剑桥,哥本哈根科学与信仰中心3,哥本哈根,4个开放患者数据探索网络,OUH,5 ......................................................................................... 161 Triangulation of Contradictory Evidence From Three Randomized Trials of An Early 2-Dose Measles Schedule in Guinea-Bissau From 2003-2019 Sebastian Nielsen, Bandim Health Project, Department of Clinical Research, SDU, and Sdu, and Sören Möller, Open Patient Data Explorative Network (Open), Department of Clinical Research, University of Southern Denmark ........................................................... 173 Estimating Healthcare Transitions: Integrating Logistic Regression and Markov Models to Predict Mortality from Continuity and Discoontinuity of Care Troels Kristensen,Dache,丹麦南部公共卫生系.......................................................................................................................................................................1核医学系OUH,2临床研究系,SDU,SDU 3,巴塞尔3号医学质量与研究学院,瑞士和4体育科学与临床生物力学系,南丹麦大学.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................1核医学系OUH,2临床研究系,SDU,SDU 3,巴塞尔3号医学质量与研究学院,瑞士和4体育科学与临床生物力学系,南丹麦大学.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................
1. Chaudhuri A、Ghanim H、Arora P。改善糖尿病肾病肾脏和心血管结局的残余风险:对最近试验的病理生理学、机制和证据的回顾。糖尿病、肥胖、代谢。2022;24(3):365-376。2. Rossing P、Caramori ML、Chan JCN 等人。KDIGO 2022 慢性肾脏病糖尿病管理临床实践指南执行摘要:基于快速出现的新证据的更新。肾脏国际。2022;102(5):990-999。3. Neuen BL、Ohkuma T、Neal B 等人。卡格列净对不同水平白蛋白尿患者肾脏和心血管结局的影响:来自 CANVAS 计划的数据。美国肾脏学会杂志。 2019;30(11):2229-2242。4. Bakris GL、Agarwal R、Anker SD 等人。Finerenone 对 2 型糖尿病慢性肾病结果的影响。N Engl J Med。2020;383(23):2219-2229。5. Heerspink HJL、Karasik A、Thuresson M 等人。真实世界临床实践中使用 SGLT2 抑制剂相关的肾脏结果(CVD-REAL 3):一项多国观察性队列研究。柳叶刀糖尿病内分泌学。2020;8(1):27-35。6. Aggarwal R、Chiu N、Bhatt DL。DAPA-CKD 在美国的普及性。Circ Cardiovasc Qual Outcomes。 2021;14(7):e007875。7. 肾脏疾病:改善全球预后糖尿病工作 G. KDIGO 2020 慢性肾脏病糖尿病管理临床实践指南。肾脏国际。2020;98(4S):S1-S115。8. Gaede P、Vedel P、Parving HH、Pedersen O. 强化多因素干预对 2 型糖尿病患者和
Figure 1: Overview Legislation regarding in-cabin monitoring 7 Figure 2: Overview automotive safety institutions 8 Figure 3: Overview consumer test organizations 13 Figure 4: Metaphor for in-cabin monitoring systems as a butler 14 Figure 5: Overview of applications from user requirements study 15 Figure 6: Selection of companies working on DMS 15 Figure 7: Overview applications on market 16 Figure 8: Melexis ToF sensor specifications 16 Figure 9: OMS检测功能来自NIR和深度图像17图10:DMS检测功能与Metexis TOF及其NIR图像传感器18图11:来自消费电子电子的概述应用18图12:来自Daimler Truck(FUSO)的Quirin Anker(FUSO)19图13:应用程序23:使用PRIO 1的应用程序23:启动PRIO 1应用程序应用程序,以启用相机技术,以启用相机技术,以启用启用相机技术。28 Figure 15: Elena Zhelondz, A2MAC1 31 Figure 16: Sensors used for in-cabin monitoring 31 Figure 17: Most popular locations of DMCs 32 Figure 18: Average cost of interior sensors 32 Figure 19: Prof. Dr. Rainer Stiefelhagen 34 Figure 20: Prof. Dr. Jürgen Beyerer 35 Figure 21: Typical camera positions with different lens opening angles 38 Figure 22: Martin Lass, Infineon 39图23:评估的测量功能概述40图24:五个不同的相机位置的模拟传感器数据和驱动程序的两个不同次级活动40图25:ChatGpt4 2024年4月,根据卡宾蛋白室内图像43图26:用于驾驶员活动的驱动器和ACT数据集的驾驶员和ACT数据集的警告43:预期技术的驱动器和ACT数据集43:预期的技术<43:43:预期的技术<43:43:43:43
1- Cour des Comptes,Rapport public annuel(年度公开报告),2020 年 2 月。来源:www.ccomptes.fr 2- Klingberg F.、Hinz B.、White ES,肌成纤维细胞基质:对组织修复和纤维化的影响。J Pathol,2013 年;229:298-309。3- Boffa JJ、Tharaux PL、Placier S.、Ardaillou R. 等人,血管紧张素 II 在抑制一氧化氮合成过程中激活转基因小鼠肾血管中的 I 型胶原基因:内皮素介导机制的证据。Circulation,1999 年;100:1901-1908。 4- Bailey CJ、Day C.、Bellary S.,SGLT2 抑制剂的肾脏保护作用:对急性和慢性肾脏疾病的影响,Curr Diab Rep,2022;22:39-52。5- Simms-Williams N.、Treves N.、Yin H. 等人,胰高血糖素样肽-1 受体激动剂和钠-葡萄糖协同转运蛋白-2 抑制剂联合治疗对心血管和严重肾脏事件发生率的影响:基于人群的队列研究 BMJ,2024:385:e078242。6- Rheault MN、Alpers CE、Barratt J. 等人,Sparsentan 与厄贝沙坦在局灶性节段性肾小球硬化症中的比较,N Engl J Med,2023;389:2436-2445。 7- Bakris GL, Agarwal R., Anker SD 等,Finerenone 对 2 型糖尿病患者慢性肾病结局的影响,N Engl J Med,2020;383:2219-2229。8- Corréas JM, Anglicheau D., Gennisson JL 等,肾弹性成像。肾脏病治疗,2016;12:S25-S34。9- Massol J., Janin G., Bachot C. 等,试点非透析慢性肾功能不全研究(P-ND-CRIS):一项开放前瞻性法国医院队列试点研究,BMC Nephrol,2016;17:92。 10- Midgley AC、Wei Y.、Zhu D. 等人,多功能天然聚合物纳米粒子作为 CKD 治疗的抗纤维化基因载体,J Am Soc Nephrol,2020; 31:2292-2311。 11-科曼·R.,查吉克里斯托斯·E。 et Chatziantoniou C.,Fibrose rénale:peut-elle être Traitée ? 【肾纤维化:能治疗吗?】牛。阿卡德。纳特尔医学,2017,201,P; 785-797